FDA issues ’emergency use’ green light for Gilead’s remdesivir
The move follows data from a clinical trial showing that the drug accelerated recovery time in hospitalised patients
Read More
Tag: emergency use
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
